欧拉羊种公羊适应性观察与杂交改良乔科羊繁殖力分析

欧拉羊引入甘南州大水种畜场和碌曲县尕海乡、郎木寺镇等地改良乔科羊的肉用性能,引入的欧拉羊种公羊行为表现正常,抗寒、抗病能力较强,发病率为7％以下,死亡率在3％以下。繁殖性能和生长发育良好,主要生理生化指标都在正常范围之内。欧拉羊杂交改良乔科羊的繁殖力分析结果表明,用欧拉羊杂交改良乔科羊试验组的母羊受胎率、繁殖率、羔羊成活率及繁殖成活率均比当地乔科羊本交对照组分别提高1．45％、1．07％、4．06％和4．71％。     

Effect of renal insufficiency on the pharmacokinetics and pharmacodynamics of benazepril in cats

The effect of renal insufficiency was studied on the pharmacokinetics (PK) and pharmacodynamics (PD) of the angiotensin-converting enzyme (ACE) inhibitor benazepril in cats. The active metabolite of benazepril, benazeprilat, is eliminated principally ( approximately 85%) via biliary excretion in cats. A total of 20 control animals and 32 cats with moderate renal insufficiency induced by partial nephrectomy were used. Assessments were made at steady state after treatment with placebo or benazepril (0.25-2 mg/kg) once daily for a minimum of 10 days. The PK endpoint was the AUC (0-->24 h) of total plasma benazeprilat. The PD endpoints were systolic, diastolic and mean blood pressures (respectively SBP, DBP and MBP) measured by telemetry, and plasma ACE activity, assessed by an ex vivo assay. Renal function was assessed by glomerular filtration rate (GFR), measured by inulin clearance, and plasma creatinine concentrations (1/PCr). As compared with control animals, the renal insufficient cats had a 78% reduction in GFR (0.57 +/- 0.41 mL/min kg), increased plasma creatinine (2.7 +/- 1.0 mg/dL), urea (44.0 +/- 11.9 mg/dL) and ACE activity, and moderately increased blood pressure (SBP 171.8 +/- 5.1 mmHg) (all parameters P < 0.05). Renal insufficient cats receiving benazepril had significantly (P < 0.05) lower SBP, DBP, MBP and ACE, and higher GFR values as compared with placebo-treated animals. There were no significant differences in SBP, DBP, MBP, benazeprilat or ACE values according to the degree of renal insufficiency in cats receiving benazepril. It is concluded that no dose adjustment of benazepril is necessary in cats with moderate renal insufficiency.     

Dose confirmation studies for monepantel, an amino-acetonitrile derivative, against fourth stage gastro-intestinal nematode larvae infecting sheep

Monepantel is the first compound from the recently discovered amino-acetonitrile derivative (AAD) class of anthelmintics to be developed for use in sheep. Nine dose confirmation studies were conducted in Australia, New Zealand and Switzerland to confirm the minimum therapeutic oral dose of monepantel to control fourth stage (L4) gastro-intestinal nematode larvae in sheep (target species were Haemonchus contortus, Teladorsagia (Ostertagia) circumcincta, Teladorsagia trifurcata, Trichostrongylus axei, Trichostrongylus colubriformis, Trichostrongylus vitrinus, Cooperia curticei, Cooperia oncophora, Nematodirus battus, Nematodirus filicollis, Nematodirus spathiger, Chabertia ovina and Oesophagostomum venulosum). In each study, sheep infected with a defined selection of the target nematodes were treated with 2.5 mg monepantel/kg liveweight. Following euthanasia and worm counting, efficacy was calculated against worm counts from untreated control groups. The results demonstrate high (95 < 100%) efficacy of monepantel when administered orally to sheep at 2.5 mg/kg for most species tested. Efficacy levels against N. spathiger and O. venulosum were variable and failed to meet the required regulatory standard (≥90%) in some studies. Efficacy was demonstrated against L4 stages of nematodes known to be resistant to either benzimidazole and/or levamisole anthelmintics (macrocyclic lactone resistant isolates were not available for testing). The broad-spectrum activity of monepantel against L4 larvae of common gastro-intestinal nematodes in sheep and its favorable safety profile represents a significant advance in the treatment of parasitic gastro-enteritis in this animal species. No adverse effects related to treatment with monepantel were observed.     

阴外动脉灌注氨基酸对奶山羊乳腺摄取乳成分前体物的影响

 【目的】研究阴外动脉灌注不同平衡模式的氨基酸对奶山羊乳腺摄取乳成分前体物（milk components precursors,MCP）的影响规律。【方法】选用2—3周岁,体重、产奶量相近、安装有阴外动脉和腹部皮下静脉血插管的关中奶山羊3只,由阴外动脉灌注不同平衡模式的氨基酸,在灌注前后分别采集动静脉血浆,测定乳蛋白前体物（milk protein precursors,MPP）、乳脂前体物（milk fat precursors,MFP）和乳糖前体物（milk lactose precursors,MLP）的含量和乳腺对其的摄取。【结果】阴外动脉灌注不同平衡模式混合氨基酸改变了乳腺对MPP、MFP的摄取（P＜0.05）,乳腺对MLP的摄取理想模式组和平衡模式组均高于不灌注组,但理想模式组与不灌注组差异不显著（P＞0.05）,平衡模式组与不灌注组差异显著（P＜0.05）;不同氨基酸模式灌注组产奶量和乳成分明显高于对照组（P＜0.05）。【结论】阴外动脉中氨基酸的平衡改变了乳腺对乳成分前体物的摄取,有利于乳的合成。本试验条件下,阴外动脉中必需氨基酸达到理想平衡（AABI=0.972）时乳腺对MCP的摄取效果最佳。